Clinical Trial Update: A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function. [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the elimination and tolerability of a single dose of PD 0332334 in healthy subjects compared with patients with impaired kidney fun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Insufficiency

Drugs mentioned

• PD 0332334

Snippet

Sponsor: Pfizer | Conditions: Renal Insufficiency, Pharmacokinetics | Phase 1 | Status: TERMINATED